The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Novavax COVID-19 vaccine now available for Michigan residents ages 18 and older
August 11, 2022
Michigan residents ages 18 and older now have another COVID-19 vaccine option – Novavax – to help protect them from serious illness and death due to the virus.
On July 13, the U.S. Food and Drug Administration issued an Emergency Use Authorization for Novavax COVID-19 vaccine for use among people ages 18 years and older for a two-dose primary series. This was followed by Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices’ recommendation for use of the Novavax COVID-19 vaccine in this population and endorsement by CDC.
“Having multiple types of vaccine offers more options and flexibility for people receiving COVID-19 vaccines,” said Dr. Natasha Bagdasarian, MDHHS chief medical executive. “COVID-19 vaccines remain our best defense against the virus, helping prevent serious illness and death. We continue to urge Michiganders who have not yet been vaccinated to get the vaccine as soon as possible.”
The Novavax COVID-19 vaccine is the first COVID-19 protein subunit vaccine recommended for use in the United States. During clinical trials, it was found to be over 90% effective in preventing serious illness from COVID-19. Adults ages 18 years and older should receive a two-dose primary series separated by three to eight weeks. A shorter interval of three weeks between the first and second doses is recommended for:
- People who are moderately or severely immunocompromised.
- Adults ages 65 years and older.
- In situations in which there is increased concern about COVID-19 community levels or an individual’s higher risk of severe disease.
Currently, a booster dose using any COVID-19 vaccine is not authorized for adults in this age group who receive a Novavax primary series. A limited number of doses of Novavax COVID-19 vaccine will be distributed and not all providers are expected to carry Novavax COVID-19 vaccine. In Michigan, about 100,000 doses are available for order by vaccine providers. To locate providers offering Novavax, visitvaccines.gov.
To date, over 6.7 million Michiganders ages 5 and up have gotten at least their first dose of safe and effective COVID-19 vaccines. Eligible Michiganders are encouraged to stay up to date on vaccinations, which includes booster doses that provide extra protection, and residents of long-term care facilities where outbreaks can spread quickly and extra protection is strongly recommended.
MDHHS also encourages Michigan residents to pay attention to local guidance as some communities may be at a higher risk of COVID-19 transmission.
To schedule a primary or booster dose of the COVID vaccine, visit vaccines.gov.
To learn more about the COVID-19 vaccine, visit Michigan.gov/COVIDvaccine.
For more information about COVID-19 in Michigan, visit Michigan.gov/coronavirus.
# # #
Additional Novavax resources:
- COVID-19 Vaccine Schedule
- COVID-19 Vaccines for People who are Moderately or Severely Immunocompromised | CDC
- Novavax COVID-19, Adjuvanted Vaccine: Overview and Safety | CDC
- Understanding Protein Subunit COVID-19 Vaccines | CDC
- Stay Up to Date with Your COVID-19 Vaccines | CDC